MSH2 and colorectal carcinoma: In terms of lifetime CRC risks, individuals in both the MLH1 and MSH2 groups exhibited higher lifetime risks compared to individuals in the MSH6 group, with HRs of 3.5 (95% CI 1.8–6.7) and 2.4 (95% CI 1.2–4.9), respectively.